Professional Media briefs

Share this article:

Dove Medical Press announced the appointment of Dr. Jerry Bagel as the editor-in-chief of its new journal, Psoriasis: Targets and Therapy. This international, peer-reviewed open-access journal focuses on therapies for psoriasis. Bagel, a nationally recognized expert in the treatment of psoriasis, is also director of the Psoriasis Treatment Center of Central New Jersey in East Windsor. 

Elsevier has launched an iPhone and iPad app version of its signature cardiology and heart disease textbook Brunwald's Heart Disease: A Textbook of Cardiovascular Medicine called Brunwald's Heart Disease Practice Guide. The app, which makes available content from the 9th edition of the global cardiology publication, provides up-to-date, evidence-based cardiology clinical practice guidelines from the American College of Cardiology and the American Heart Association.

BMJ Group appointed Seema Biswas as editor-in-chief of BMJ Case Reports, which is home to the largest single collection of medical case reports on the web, encompassing more than 2,500 published contributions in every discipline. Biswas, has held the post of lead clinical editor for onExamination, a tool produced by BMJ Learning, since May 2010.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?